An open trial of electronic cigarettes for smoking cessation among methadone-maintained smokers

Nicotine and Tobacco Research

Volumn 18, Issue 5, 2016, Pages 1157-1162

  Stein, Michael D ^a,b   Caviness, Celeste ^a   Grimone, Kristin ^a   Audet, Daniel ^a   Anderson, Bradley J ^a   Bailey, Genie L ^b,c  

^a BUTLER HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c Stanley Street Treatment and Resources Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CIGARETTES PER DAY; CLINICAL TRIAL; CONCENTRATION LOSS; COUGHING; DIZZINESS; EDUCATIONAL STATUS; ELECTRONIC CIGARETTE; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; HEADACHE; HUMAN; INCREASED APPETITE; MALE; METHADONE MAINTAINED SMOKER; MIDDLE AGED; MISCELLANEOUS NAMED GROUPS; OUTCOME ASSESSMENT; PARAMETERS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; SLEEP DISORDER; SMOKING CESSATION; SORE THROAT; TREATMENT DURATION; WITHDRAWAL SYNDROME; XEROSTOMIA; OPIATE SUBSTITUTION TREATMENT; PROCEDURES; TOBACCO USE DISORDER;

METHADONE;

ADULT; ELECTRONIC CIGARETTES; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84964928005     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv267     Document Type: Article

References (78)

1. McCool RM, Paschall Richter K. Why do so many drug users smoke? J Subst Abuse Treat. 2003;25(1):43-49.
2. Okoli CT, Khara M, Procyshyn RM, Johnson JL, Barr AM, Greaves L. Smoking cessation interventions among individuals in methadone maintenance: a brief review. J Subst Abuse Treat. 2010;38(2):191-199. doi:S0740-5472(09)00166-4 [pii] 10.1016/j.jsat.2009.10.001.
3. Richter KP, Gibson CA, Ahluwalia JS, Schmelzle KH. Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health. 2001;91(2):296-299.
4. Nahvi S, Richter K, Li X, Modali L, Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict Behav. 2006;31(11):2127-2134. doi:10.1016/j.addbeh.2006.01.006.
5. Centers for Disease Control and Prevention. State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18-35 years--United States, 2006. MMWR Morb Mortal Wkly Rep. 2007;56(38):993-996.
6. Hurt RD, Offord KP, Croghan IT, et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996;275(14):1097-1103.
7. Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med. 1994;23(1):61-69. doi:10.1006/pmed.1994.1009.
8. Clarke JG, Stein MD, McGarry KA, Gogineni A. Interest in smoking cessation among injection drug users. Am J Addict. 2001;10(2):159-166.
9. Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population- based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002;97(7):861-869.
10. Shoptaw S, Rotheram-Fuller E, Yang X, et al. Smoking cessation in methadone maintenance. Addiction. 2002;97(10):1317-1328; discussion 1325.
11. Stein MD, Weinstock MC, Herman DS, Anderson BJ, Anthony JL, Niaura R. A smoking cessation intervention for the methadone-maintained. Addiction. 2006;101(4):599-607. doi:10.1111/j.1360-0443.2006.01406.x.
12. Reid MS, Fallon B, Sonne S, et al. Smoking cessation treatment in community- based substance abuse rehabilitation programs. J Subst Abuse Treat. 2008;35(1):68-77. doi:10.1016/j.jsat.2007.08.010.
13. Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA. 1994;271(8):595-600.
14. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;1:CD000146. doi:10.1002/14651858.CD000146.pub3.
15. Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M. Preliminary study of buprenorphine and bupropion for opioid- dependent smokers. Am J Addict. 2008;17(4):287-292. doi:10.1080/10550490802138814.
16. Stein MD, Caviness CM, Kurth ME, Audet D, Olson J, Anderson BJ. Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. Drug Alcohol Depend. 2013;133(2):486-493. doi:10.1016/j.drugalcdep.2013.07.005.
17. Okoli CT, Khara M, Procyshyn RM, Johnson JL, Barr AM, Greaves L. Smoking cessation interventions among individuals in methadone maintenance: a brief review. J Subst Abuse Treat. 2010;38(2):191-199. doi:10.1016/j.jsat.2009.10.001.
18. King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and everuse of electronic cigarettes among U.S. Adults, 2010-2011. Nicotine Tob Res. 2013;15(9):1623-1627. doi:10.1093/ntr/ntt013.
19. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tob Control. 2013;22(1):19-23. doi:10.1136/tobaccocontrol-2011-050044.
20. Adkison SE, O'Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013;44(3):207-215. doi:10.1016/j.amepre.2012.10.018.
21. Choi K, Forster J. Characteristics associated with awareness, perceptions, and use of electronic nicotine delivery systems among young US Midwestern adults. Am J Public Health. 2013;103(3):556-561. doi:10.2105/AJPH.2012.300947.
22. Loomis BR, Rogers T, King BA, et al. National and state-specific sales and prices for electronic cigarettes-U.S., 2012-2013. [published online ahead of print June 29, 2015] Am J Prev Med. doi:10.1016/j.amepre.2015.05.003.
23. Ayers JW, Ribisl KM, Brownstein JS. Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. Am J Prev Med. 2011;40(4):448-453. doi:10.1016/j. amepre.2010.12.007.
24. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health. 2010;10:231. doi:10.1186/1471-2458-10-231.
25. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011;106(11):2017-2028. doi:10.1111/j.1360-0443.2011.03505.x.
26. Foulds J, Veldheer S, Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract. 2011;65(10):1037-1042. doi:10.1111/j.1742-1241.2011.02751.x.
27. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev. 2013;32(2):133-140. doi:10.1111/j.1465-3362.2012.00512.x.
28. Dawkins L, Turner J, Roberts A, Soar K. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction. 2013;108(6):1115-1125. doi:10.1111/add.12150.
29. Bullen C, Williman J, Howe C, et al. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health. 2013;13:210. doi:10.1186/1471-2458-13-210.
30. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629-1637. doi:10.1016/S0140-6736(13)61842-5.
31. Rahman MA, Hann N, Wilson A, Worrall-Carter L. Electronic cigarettes: patterns of use, health effects, use in smoking cessation and regulatory issues. Tob Induc Dis. 2014;12(1):21. doi:10.1186/1617-9625-12-21.
32. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction. 2015;110(7):1160-1168. doi:10.1111/ add.12917.
33. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109(9):1531-1540. doi:10.1111/add.12623.
34. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317. doi:10.1371/journal.pone.0066317.
35. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011;11:786. doi:10.1186/1471-2458-11-786.
36. Polosa R, Morjaria JB, Caponnetto P, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2014;9(5):537-546. doi:10.1007/s11739-013-0977-z.
37. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med. 2011;40(4):472-475. doi:10.1016/j.amepre.2010.12.006.
38. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health. 2013;10(2):446-461. doi:10.3390/ijerph10020446.
39. Cobb NK, Abrams DB. E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med. 2011;365(3):193-195. doi:10.1056/NEJMp1105249.
40. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control. 2010;19(1):87-88. doi:10.1136/tc.2009.033498.
41. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013;15(1):158-166. doi:10.1093/ntr/nts103.
42. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1945-1953. doi:10.1158/1055- 9965.EPI-10-0288.
43. Brandon TH, Goniewicz ML, Hanna NH, et al. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clin Cancer Res. 2015;21(3):514-525. doi:10.1158/1078-0432.CCR-14-2544.
44. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23(suppl 2):ii11-17. doi:10.1136/tobaccocontrol-2013-051482.
45. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised crossover trial. Tob Control. 2010;19(2):98-103. doi:10.1136/tc.2009.031567.
46. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013;8(1):5. doi:10.1186/1940-0640-8-5.
47. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res. 2013;15(10):1787-1791. doi:10.1093/ntr/ntt061.
48. Stein MD, Caviness CM, Grimone K, Audet D, Borges A, Anderson BJ. E-cigarette knowledge, attitudes, and use in opioid dependent smokers. J Subst Abuse Treat. 2015;52:73-77. doi:10.1016/j.jsat.2014.11.002.
49. Nides MA, Leischow SJ, Bhatter M, Simmons M. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav. 2014;38(2):265-274. doi:10.5993/AJHB.38.2.12.
50. Sobell L, Sobell M. Timeline Followback User's Guide: A Calendar Method for Assessing Alcohol and Drug Use. Toronto, ON, Canada: Addiction Research Foundation; 1996.
51. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
52. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289-294.
53. Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15(3):271-283. doi:0306-4603(90)90070-E [pii].
54. Hall SM, Havassy BE, Wasserman DA. Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol. 1990;58(2):175-181.
55. McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199-213.
56. Allison PD. Fixed Effects Regression Models: Quantitative Applications in the Social Sciences. Thousand Oaks, CA: Sage Publications; 2009.
57. Frosch DL, Shoptaw S, Nahom D, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate- dependent individuals. Exp Clin Psychopharmacol. 2000;8(1):97-103.
58. Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 1996;382(6588):255-257. doi:10.1038/382255a0.
59. Schmitz JM, Grabowski J, Rhoades H. The effects of high and low doses of methadone on cigarette smoking. Drug Alcohol Depend. 1994;34(3):237-242.
60. Story J, Stark MJ. Treating cigarette smoking in methadone maintenance clients. J Psychoactive Drugs. 1991;23(2):203-215.
61. Spiga R, Martinetti MP, Meisch RA, Cowan K, Hursh S. Methadone and nicotine self-administration in humans: a behavioral economic analysis. Psychopharmacology (Berl). 2005;178(2-3):223-231. doi:10.1007/ s00213-004-2020-6.
62. Hayaki J, Anderson BJ, Stein MD. Perceptions of health risk susceptibility in methadone maintained smokers. J Addict Dis. 2005;24(1):73-84. doi:10.1300/J069v24n01_07.
63. Khanna N, Arnold S, Sadaphal S, Joshi A, Stewart D, Gandhi D. Nicotine dependence and depression among women smokers on methadone maintenance. Eur J Gen Pract. 2010;16(4):222-228. doi:10.3109/13814788.2 010.516359.
64. Stein MD, Anderson BJ. Nicotine and drug interaction expectancies among methadone maintained cigarette smokers. J Subst Abuse Treat. 2003;24(4):357-361.
65. Berg CJ, Barr DB, Stratton E, Escoffery C, Kegler M. Attitudes toward e-cigarettes, reasons for initiating e-cigarette use, and changes in smoking behavior after initiation: a pilot longitudinal study of regular cigarette smokers. Open J Prev Med. 2014;4(10):789-800. doi:10.4236/ ojpm.2014.410089.
66. Lam TH, Abdullah AS, Chan SS, Hedley AJ; Hong Kong Council on S, Health Smoking Cessation Health Centre Steering G. Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation. Psychopharmacology (Berl). 2005;177(4):400-408. doi:10.1007/s00213-004-1971-y.
67. Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, Gitchell JG. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, doubleblind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clin Ther. 2008;30(10):1852-1858. doi:10.1016/j. clinthera.2008.09.016.
68. Cummings KM, Hyland A, Ockene JK, Hymowitz N, Manley M. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993. Tob Control. 1997;6(suppl 2):S63-70.
69. Halperin AC, McAfee TA, Jack LM, et al. Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat. 2009;36(4):428-434. doi:10.1016/j. jsat.2008.09.001.
70. Blak BT, Wilson K, Metcalfe M, Maguire A, Hards M. Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study. Curr Med Res Opin. 2010;26(4):861-870. doi:10.1185/03007990903526461.
71. Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009;66(11):1253-1262. doi:10.1001/archgenpsychiatry.2009.142.
72. Catz SL, Jack LM, McClure JB, et al. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011;13(5):361-368. doi:10.1093/ntr/ntr003.
73. Frosch DL, Nahom D, Shoptaw S. Optimizing smoking cessation outcomes among the methadone maintained. J Subst Abuse Treat. 2002;23(4):425-430. doi:S0740547202002805 [pii].
74. Richter KP, McCool RM, Catley D, Hall M, Ahluwalia JS. Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. J Addict Dis. 2005;24(4):79-90.
75. Stein MD, Anderson BJ, Niaura R. Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers. J Gen Intern Med. 2006;21(7):753-757. doi:10.1111/j.1525-1497.2006.00504.x.
76. Stein MD, Anderson BJ, Niaura R. Smoking cessation patterns in methadone- maintained smokers. Nicotine Tob Res. 2007;9(3):421-428. doi:10.1080/14622200701188885.
77. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109(11):1801-1810. doi:10.1111/ add.12659.
78. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.